Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.4390
+0.0030 (0.69%)
At close: Feb 10, 2026
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 128.15 million as of February 11, 2026. Its market cap has decreased by -28.54% in one year.
Market Cap
128.15M
Enterprise Value
30.52M
Revenue
9.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.44
Market Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 128.15M, a decrease of -38.98%. That is a compound annual growth rate of -5.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 127.27M | 17.84% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Initiator Pharma | 196.46M |
| Sprint Bioscience AB | 179.38M |
| NextCell Pharma AB | 176.89M |
| Karolinska Development AB | 169.06M |
| Isofol Medical AB | 168.52M |
| IRLAB Therapeutics AB | 142.36M |
| Simris Group AB (PUBL) | 126.32M |
| Annexin Pharmaceuticals AB | 112.24M |